Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide vs Methazolamide for Hypoxic Exercise Performance
NCT05575180Phase 4Completed
- Sponsor
- University of Waterloo
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methazolamide in acute mountain sickness (AMS), sponsored by University of Waterloo. Started Aug 2023; status: completed.
02
Drugs
methazolamide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT05575180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575180.